{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:16:11Z","timestamp":1775459771511,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e39423","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T10:05:01Z","timestamp":1729073101000},"page":"e39423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Valsartan\/Sacubitril induced isolated angioedema of uvula: A case report"],"prefix":"10.1016","volume":"10","author":[{"given":"Maisa A.","family":"Nazzal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Iter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameed Q.","family":"Dawabsheh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majd A.","family":"Bsharat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2024.e39423_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4168\/aair.2010.2.3.195","article-title":"Angiotensin-converting enzyme inhibitors and angioedema","volume":"2","author":"S\u00e1nchez-Borges","year":"2010","journal-title":"Allergy, asthma & immunology research."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39423_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad. Emerg. Med. : official journal of the Society for Academic Emergency Medicine"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39423_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjoto.2010.11.014","article-title":"Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis","volume":"32","author":"Shino","year":"2011","journal-title":"Am. J. Otolaryngol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39423_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ehf2.12161","article-title":"ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation","volume":"4","author":"Srinivasan","year":"2017","journal-title":"ESC heart failure"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39423_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1524-6175.2002.01509.x","article-title":"Current concepts of pharmacotherapy in hypertension: ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used?","volume":"4","author":"Sica","year":"2002","journal-title":"Journal of clinical hypertension (Greenwich, Conn)"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39423_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown","year":"2017","journal-title":"Journal of clinical hypertension (Greenwich, Conn)"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39423_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/BF03022528","article-title":"Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications","volume":"53","author":"Sarkar","year":"2006","journal-title":"Can. J. Anesth."},{"issue":"28","key":"10.1016\/j.heliyon.2024.e39423_bib8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"issue":"31","key":"10.1016\/j.heliyon.2024.e39423_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011695","article-title":"Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: a case report","volume":"97","author":"Jackeviciute","year":"2018","journal-title":"Medicine"},{"issue":"7\u20138","key":"10.1016\/j.heliyon.2024.e39423_bib10","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons","year":"2003","journal-title":"Ann. Pharmacother."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39423_bib11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/BF03022528","article-title":"Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications","volume":"53","author":"Sarkar","year":"2006","journal-title":"Canadian journal of anaesthesia = Journal canadien d'anesthesie."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39423_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13256-018-1910-x","article-title":"Perindopril-induced angioedema of the lips and tongue: a case report","volume":"12","author":"Alharbi","year":"2018","journal-title":"J. Med. Case Rep."},{"issue":"45","key":"10.1016\/j.heliyon.2024.e39423_bib13","article-title":"Angioedema related to angiotensin-converting enzyme inhibitors: attack severity, treatment, and hospital","volume":"94","author":"Javaud","year":"2015","journal-title":"Admission in a Prospective Multicenter Study"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e39423_bib14","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/MJT.0b013e3181f28f84","article-title":"Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review","volume":"19","author":"Kalra","year":"2012","journal-title":"Am. J. Therapeut."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e39423_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39423_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2753.2003.00484.x","article-title":"An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors","volume":"10","author":"Morimoto","year":"2004","journal-title":"J. Eval. Clin. Pract."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39423_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1081-1206(10)60860-5","article-title":"Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"98","author":"Malde","year":"2007","journal-title":"Ann. Allergy Asthma Immunol. : official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39423_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1378\/chest.126.2.400","article-title":"Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema: clinical experience at a large community teaching hospital","volume":"126","author":"Sondhi","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e39423_bib19","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/00005537-200110000-00011","article-title":"Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology","volume":"111","author":"Chiu","year":"2001","journal-title":"Laryngoscope"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e39423_bib20","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJM199512073332316","article-title":"Angioedema induced by the angiotensin II blocker losartan","volume":"333","author":"Acker","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e39423_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1081-1206(10)60288-8","article-title":"Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis","volume":"101","author":"Haymore","year":"2008","journal-title":"Ann. Allergy Asthma Immunol. : official publication of the American College of Allergy, Asthma, & Immunology"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e39423_bib22","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archotol.130.12.1416","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists","volume":"130","author":"Kyrmizakis","year":"2004","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e39423_bib23","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1001\/archinte.158.18.2063","article-title":"Angioneurotic edema attributed to the use of losartan","volume":"158","author":"van Rijnsoever","year":"1998","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39423_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1345\/aph.19294","article-title":"Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema","volume":"34","author":"Warner","year":"2000","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39423_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2022.10.033","article-title":"Comparative risk of angioedema with sacubitril-valsartan vs renin-angiotensin-aldosterone inhibitors","volume":"81","author":"Eworuke","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e39423_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2018.03.121","article-title":"Angioedema in heart failure patients treated with sacubitril\/valsartan (LCZ696) or enalapril in the PARADIGM-HF study","volume":"264","author":"Shi","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e39423_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.HYP.25.1.37","article-title":"Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients","volume":"25","author":"Goldberg","year":"1995","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39423_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.HYP.38.2.183","article-title":"Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP","volume":"38","author":"Siragy","year":"2001","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"1 Pt 2","key":"10.1016\/j.heliyon.2024.e39423_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.HYP.31.1.349","article-title":"AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism","volume":"31","author":"Gohlke","year":"1998","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e39423_bib30","first-page":"96","article-title":"Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy","volume":"1","author":"Volpe","year":"2000","journal-title":"Ital. Heart J. : official journal of the Italian Federation of Cardiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e39423_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.0000153269.07762.3B","article-title":"Losartan increases bradykinin levels in hypertensive humans","volume":"111","author":"Campbell","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e39423_bib32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3122\/jabfm.2017.04.170111","article-title":"Angioedema spotlight: a closer examination of sacubitril\/valsartan safety results","volume":"30","author":"Owens","year":"2017","journal-title":"J. Am. Board Fam. Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024154540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024154540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:29:33Z","timestamp":1775456973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024154540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2405844024154540"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39423","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valsartan\/Sacubitril induced isolated angioedema of uvula: A case report","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e39423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e39423"}}